Metformin for primary colorectal cancer prevention in patients with diabetes: A case-control study in a US population
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin for primary colorectal cancer prevention in patients with diabetes: A case-control study in a US population
Authors
Keywords
-
Journal
CANCER
Volume 121, Issue 7, Pages 1071-1078
Publisher
Wiley
Online
2014-11-25
DOI
10.1002/cncr.29165
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
- (2012) C R Garrett et al. BRITISH JOURNAL OF CANCER
- Use of Metformin Is Not Associated with a Decreased Risk of Colorectal Cancer: A Case-Control Analysis
- (2012) M. Bodmer et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan
- (2012) Chin-Hsiao Tseng EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects
- (2012) M A Pierotti et al. ONCOGENE
- Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
- (2012) Hiroshi Noto et al. PLoS One
- Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
- (2012) Michael N. Pollak Cancer Discovery
- Metformin: An Emerging New Therapeutic Option for Targeting Cancer Stem Cells and Metastasis
- (2012) Ramandeep Rattan et al. Journal of Oncology
- Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
- (2011) Meei-Shyuan Lee et al. BMC CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes: A meta-analysis
- (2011) Z.-J. Zhang et al. DIABETES CARE
- Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
- (2010) A. DeCensi et al. Cancer Prevention Research
- Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial
- (2010) K. Hosono et al. Cancer Prevention Research
- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- Metformin: Taking away the candy for cancer?
- (2010) Mathilde Jalving et al. EUROPEAN JOURNAL OF CANCER
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
- (2010) Peter M Rothwell et al. LANCET
- Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase
- (2010) Kunihiro Hosono et al. MOLECULAR CARCINOGENESIS
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
- (2009) C. J. Currie et al. DIABETOLOGIA
- Diabetes and cancer
- (2009) Paolo Vigneri et al. ENDOCRINE-RELATED CANCER
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- (2009) Sao Jiralerspong et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin suppresses intestinal polyp growth in ApcMin/+ mice
- (2008) Ayako Tomimoto et al. CANCER SCIENCE
- Aspirin Dose and Duration of Use and Risk of Colorectal Cancer in Men
- (2007) Andrew T. Chan et al. GASTROENTEROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started